Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer-Reference-Cited by-同舟云学术

Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer

Published:2016-02-06 Issue:1 Volume:18 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Braunstein Marsela,Liao Linda,Lyttle Nicola,Lobo Nazleen,Taylor Karen J.,Krzyzanowski Paul M.,Kalatskaya Irina,Yao Cindy Q.,Stein Lincoln D.,Boutros Paul C.,Twelves Christopher J.,Marcellus Richard,Bartlett John M. S.,Spears Melanie

Funder

Ontario Institute for Cancer Research

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-016-0676-6.pdf

Reference40 articles.

1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–717.

2. Guo B, Villeneuve DJ, Hembruff SL, Kirwan AF, Blais DE, Bonin M, et al. Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure. Breast Cancer Res Treat. 2004;85:31–51.

3. Ringel I, Horwitz SB. Studies with RP 56976 (Taxotere): a semisynthetic analogue of Taxol. J Natl Cancer Inst. 1991;83:288–91.

4. Chazard M, Pellae-Cosset B, Garet F, Soares JA, Lucidi B, Lavail Y, et al. Taxol (paclitaxel), first molecule of a new class of cytotoxic agents: taxanes. Bull Cancer. 1994;81:173–81.

5. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56:185–229.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive landscape analysis of autophagy in cancer development and drug resistance;Frontiers in Immunology;2024-08-26

2. Prognostic role of HIST1H4C expression and neoadjuvant therapy efficacy in breast cancer;2024-06-20

3. Expand available targets for CAR-T therapy to overcome tumor drug resistance based on the "Evolutionary Traps";Pharmacological Research;2024-06

4. DoxoDB: A Database for the Expression Analysis of Doxorubicin-Induced lncRNA Genes;Non-Coding RNA;2023-07-13

5. Nano-drug delivery system: a promising approach against breast cancer;Therapeutic Delivery;2023-05